Literature DB >> 26158927

Prospective Randomized Intraindividual Comparison of Posterior Capsule Opacification After Implantation of an IOL With and Without Heparin Surface Modification.

Eva M Krall, Eva M Arlt, Gerlinde Jell, Clemens Strohmaier, Sarah Moussa, Alois K Dexl.   

Abstract

PURPOSE: To compare posterior capsule opacification (PCO) of a hydrophobic acrylic heparin surface modified intraocular lens (HSM-IOL) and an uncoated IOL (UC-IOL) 1 year after implantation.
METHODS: One hundred two eyes of 51 patients underwent routine phacoemulsification with randomized implantation of a HSM-IOL in one eye (the HSM-IOL group) and a UC-IOL in the fellow eye (the UC-IOL group). Morphologic PCO evaluation was performed comparing digital photographs in retroillumination using the Evaluation of Posterior Capsule Opacification (EPCO) system, grading the density of the opacification from 0 to 4 (0 = none, 1 = minimal, 2 = mild, 3 = moderate, and 4 = severe). Distance visual acuities, subjective manifest refraction, pupil size, straylight measurements, flare in the anterior chamber using a laser flare meter, and contrast sensitivity were also evaluated.
RESULTS: The mean total EPCO score was slightly higher in the HSM-IOL group (0.50 ± 0.45) compared to the UC-IOL group (0.45 ± 0.46), but did not reach statistical significance. No statistically significant differences were found in the other main outcome parameters (straylight measurement, distance visual acuities, flare in the anterior chamber, and mesopic and photopic contrast sensitivity) when comparing both IOLs.
CONCLUSION: Although the HSM-IOL showed decreased flare 1 day postoperatively, no statistically significant differences regarding PCO were found 1 year postoperatively. Copyright 2015, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26158927     DOI: 10.3928/1081597X-20150623-05

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  6 in total

1.  Cataract surgeon viewpoints on the need for novel preventative anti-inflammatory and anti-posterior capsular opacification therapies.

Authors:  Mahbubul H Shihan; Samuel G Novo; Melinda K Duncan
Journal:  Curr Med Res Opin       Date:  2019-08-28       Impact factor: 2.580

2.  Anti-Adhesive And Antiproliferative Synergistic Surface Modification Of Intraocular Lens For Reduced Posterior Capsular Opacification.

Authors:  Yuemei Han; Junmei Tang; Jiayi Xia; Rui Wang; Chen Qin; Sihao Liu; Xia Zhao; Hao Chen; Quankui Lin
Journal:  Int J Nanomedicine       Date:  2019-11-19

Review 3.  A Critical Appraisal of New Developments in Intraocular Lens Modifications and Drug Delivery Systems for the Prevention of Cataract Surgery Complications.

Authors:  Ioanna Mylona; Ioannis Tsinopoulos
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-08

4.  Facile multifunctional IOL surface modification via poly(PEGMA-co-GMA) grafting for posterior capsular opacification inhibition.

Authors:  Jiayi Xia; Duoduo Lu; Yuemei Han; Jiahao Wang; Yueze Hong; Peiyi Zhao; Qiuna Fang; Quankui Lin
Journal:  RSC Adv       Date:  2021-03-08       Impact factor: 3.361

5.  Augmented cellular uptake and homologous targeting of exosome-based drug loaded IOL for posterior capsular opacification prevention and biosafety improvement.

Authors:  Siqing Zhu; Huiying Huang; Dong Liu; Shimin Wen; Liangliang Shen; Quankui Lin
Journal:  Bioact Mater       Date:  2022-02-26

Review 6.  Research Progress Concerning a Novel Intraocular Lens for the Prevention of Posterior Capsular Opacification.

Authors:  Yidong Zhang; Chengshou Zhang; Silong Chen; Jianghua Hu; Lifang Shen; Yibo Yu
Journal:  Pharmaceutics       Date:  2022-06-25       Impact factor: 6.525

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.